OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist

被引：0
|
作者：
机构：
来源：
| 1600年 / 252期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] A molecular model of agonist and nonpeptide antagonist binding to the human V1 vascular vasopressin receptor
    Thibonnier, M
    Coles, P
    Conarty, DM
    Plesnicher, CL
    Shoham, M
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 294 (01): : 195 - 203
  • [32] Protective effect of a vasopressin-1 selective antagonist, OPC-21268, against ethanol-induced damage of the rat gastric wall
    Sugimoto, I
    Narimiya, N
    Odagiri, M
    Ohnishi, A
    Tanaka, T
    DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (03) : 503 - 509
  • [33] Protective Effect of a Vasopressin-1 Selective Antagonist, OPC-21268, Against Ethanol-Induced Damage of The rat Gastric Wall
    Izumi Sugimoto
    Norichika Narimiya
    Masazumi Odagiri
    Akihiro Ohnishi
    Teruji Tanaka
    Digestive Diseases and Sciences, 1999, 44 : 503 - 509
  • [34] EFFECTS OF AN ORALLY ACTIVE VASOPRESSIN V(1)-RECEPTOR ANTAGONIST
    BURRELL, LM
    PHILLIPS, PA
    STEPHENSON, J
    RISVANIS, J
    HUTCHINS, AM
    JOHNSTON, CI
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1993, 20 (05) : 388 - 391
  • [35] VPA-985, a nonpeptide orally active and selective vasopressin V2 receptor antagonist
    Chan, PS
    Coupet, J
    Park, HC
    Lai, F
    Hartupee, D
    Cervoni, P
    Dusza, JP
    Albright, JD
    Ru, X
    Mazandarani, H
    Tanikella, T
    Shepherd, C
    Ochalski, L
    Bailey, T
    Lock, TYW
    Ning, XP
    Taylor, JR
    Spinelli, W
    VASOPRESSIN AND OXYTOCIN: MOLECULAR, CELLULAR, AND CLINICAL ADVANCES, 1998, 449 : 439 - 443
  • [36] Synthesis and characterization of orally active nonpeptide arginine vasopressin V2 receptor antagonist.
    Ohkawa, T
    Setoi, H
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 104 - MEDI
  • [37] OPC-21268 ANTAGONIZES ARGININE VASOPRESSIN-INDUCED VASOCONSTRICTOR RESPONSE IN THE SPINALLY-ANESTHETIZED DOG
    CHIHARA, T
    NAKAMURA, S
    ONOGAWA, T
    YAMASHITA, T
    YAMAMURA, Y
    MORI, T
    TOMINAGA, M
    YABUUCHI, Y
    JAPANESE JOURNAL OF PHARMACOLOGY, 1995, 68 (03): : 345 - 347
  • [38] Antidiuretic effects of a nonpeptide vasopressin V2-receptor agonist, OPC-51803, administered orally to rats
    Nakamura, S
    Hirano, T
    Tsujimae, K
    Aoyama, M
    Kondo, K
    Yamamura, Y
    Mori, T
    Tominaga, M
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 295 (03): : 1005 - 1011
  • [39] IMPROVED SKIN BLOOD-FLOW AND CUTANEOUS TEMPERATURE IN THE FOOT OF A PATIENT WITH ARTERIOSCLEROSIS OBLITERANS BY VASOPRESSIN V1 ANTAGONIST (OPC21268) - A CASE-REPORT
    TOBA, K
    OUCHI, Y
    AKISHITA, M
    KOZAKI, K
    ISHIKAWA, M
    NAGANO, K
    ETOH, M
    HASHIMOTO, M
    LIANG, J
    UEDA, N
    ORIMO, H
    ANGIOLOGY, 1995, 46 (11) : 1027 - 1033
  • [40] DISTINCT MECHANISMS OF ACTION OF V1 ANTAGONISTS OPC-21268 AND [D(CH2)5TYR(ME)AVP] IN MESANGIAL CELLS
    JAMIL, KMA
    WATANABE, T
    NAKAO, A
    OKUDA, T
    KUROKAWA, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 193 (02) : 738 - 743
12345